Hepatitis; Virus, Chronic, Type B Clinical Trial
Official title:
An Exploratory, Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy and Safety of Tenofovir With and Without DWPUR001 in Patients With Hepatitis B Virus(HBV)
The patient who meets the inclusion/exclusion criteria is assigned to Test1 group or Test 2
group or control group randomly.
All subjects take one pill of Viread® Tab. (Tenofovir Disoproxil Fumarate 300mg) once a day
for 48 weeks. At the same time, all randomized subjects take two pills of DWPUR001 or Placebo
of DWPUR001 twice a day for 48 weeks.
n/a